Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia

Here, we present a case of chronic myeloid leukemia for which imatinib therapy was initated. Triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone was normal, and thyroid microsomal autoantibodies (TMA) were positive and patient was diagnosed as thyroiditis treated with corticostero...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Surjit, Sharma, Pramod Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980940/
https://www.ncbi.nlm.nih.gov/pubmed/27756963
http://dx.doi.org/10.4103/0253-7613.186214
_version_ 1782447542857891840
author Singh, Surjit
Sharma, Pramod Kumar
author_facet Singh, Surjit
Sharma, Pramod Kumar
author_sort Singh, Surjit
collection PubMed
description Here, we present a case of chronic myeloid leukemia for which imatinib therapy was initated. Triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone was normal, and thyroid microsomal autoantibodies (TMA) were positive and patient was diagnosed as thyroiditis treated with corticosteroids for 1½ months which lead to resolution.
format Online
Article
Text
id pubmed-4980940
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49809402016-10-18 Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia Singh, Surjit Sharma, Pramod Kumar Indian J Pharmacol Drug Watch Here, we present a case of chronic myeloid leukemia for which imatinib therapy was initated. Triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone was normal, and thyroid microsomal autoantibodies (TMA) were positive and patient was diagnosed as thyroiditis treated with corticosteroids for 1½ months which lead to resolution. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4980940/ /pubmed/27756963 http://dx.doi.org/10.4103/0253-7613.186214 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Drug Watch
Singh, Surjit
Sharma, Pramod Kumar
Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia
title Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia
title_full Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia
title_fullStr Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia
title_full_unstemmed Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia
title_short Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia
title_sort imatinib-induced thyroiditis in philadelphia chromosome-positive chronic myeloid leukemia
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980940/
https://www.ncbi.nlm.nih.gov/pubmed/27756963
http://dx.doi.org/10.4103/0253-7613.186214
work_keys_str_mv AT singhsurjit imatinibinducedthyroiditisinphiladelphiachromosomepositivechronicmyeloidleukemia
AT sharmapramodkumar imatinibinducedthyroiditisinphiladelphiachromosomepositivechronicmyeloidleukemia

Ejemplares similares